Making native-like HIV-1 Env trimers. The importance of both Env design and the purification method. John P. Moore Weill Cornell Medical College
|
|
- Kimberly McGee
- 6 years ago
- Views:
Transcription
1 Making native-like HIV-1 Env trimers The importance of both Env design and the purification method John P. Moore Weill Cornell Medical College
2 Env proteins are usually not homogeneous Implications for purification Irrespective of the design (gp120 monomers, uncleaved gp140s, SOSIP.664 trimers), Env protein transfection supernatants contain multiple molecular species. Unwanted sub-populations can sometimes be eliminated on the basis of size (e.g., higher m.wt. forms by SEC). Other unwanted sub-populations have the same m.wt. as the desired product and cannot be size-fractionated. These problem proteins include non-native trimers and SSscrambled gp120 subunits. Hence attention must be given to purification methods.
3 Purifying Env proteins via a tag (e.g., a C-terminal His-tag) (similar issues can apply when using lectin columns) Input Mixture of native and non-native Env proteins, all with a tag All the input Env proteins bind to the column via the tag Elution Native Env with His-Tag The native and non-native Env proteins are all eluted from the column Non-native Env with His-Tag SEC can only remove non-native forms that differ in size
4 His-tags and lectin columns Both these strategies are best avoided for making nativelike SOSIP.664 trimers. Neither method is selective for native structures. Hence any non-native trimer subpopulations present will co-purify. For BG505 SOSIP.664 trimers, His-tag columns do work adequately, but these trimers are very forgiving (low % of non-native forms). Lectin columns can allow co-purification of antigenically inappropriate trimers (aberrant glycans?), as seen with the ZM197M clade C construct (Julien et al., submitted). There are also concerns about co-purifying cellular/serum glycoproteins that are hard to remove by SEC.
5 bnab columns for Env purification bnabs select for Env protein sub-populations that display the relevant epitope. In most cases, that means a properly folded Env protein can be purified. bnabs can be used to purify native-like trimers and the native fraction of gp120 monomers. It is highly unlikely that bnab columns can rescue uncleaved gp140s as the native structure content is too low. Multiple different bnabs are now known to a range of epitopes. Several are now being made under GMP conditions for clinical trials as therapeutics. bnab-env affinity is relevant: Too low, poor binding; Too high, poor recovery. In practice, most bnabs seem to be broadly in the right affinity range.
6 Purifying native trimers via bnab columms We strongly favor bnab affinity columns over any other technique, particularly C-terminal tags (e.g., His-tags). (Applies also to gp120 monomers). Standard method involves 2G12 columns followed by SEC. Positive selection columns using a quaternary-specific bnab (PGT145, PGT151) offer a simple way to select for native trimers when non-native forms are also present. For pre-clinical work, a PGT145/PGT151 column eliminates the need for an SEC column (i.e., one-step purification). Negative-selection methods (e.g., lectin/sec/f105) are complicated (3 columns) and offer no advantages. Also hard to see them as applicable to GMP production.
7 Epitopes for bnabs used to purify BG505 SOSIP.664 trimers Top View Side View Membrane 2G12 PGT145 PGT151 2G12 is not trimer-specific and will bind gp120 monomers. Although 2G12 has some selectivity for properly folded gp120 subunits, it will bind non-native forms of Env. PGT145 and PGT151 bind trimer-specific quaternary epitopes.
8 Input Mixture of native (epitope present) and non-native Env proteins (epitope absent) Purifying Env proteins via bnabs that select for a native conformation (trimer-specific or not) The native Env proteins bind to the bnab on the column Elution Examples 2G12 PGT145 PGT151 Native Env Non-Native Env The non-native Env proteins flow through the column and are discarded The native Env proteins are eluted and collected SEC still needed to purify trimer fraction unless quaternary bnab (PGT145, PGT151) used
9 2G12 columns for purifying SOSIP.664 trimers Most of our experience is with 2G12 (available as GMP reagent from Polymun, after clinical studies in 2008). Broadly reactive although less so with clade C Env. Key glycans can be knocked-in to restore epitope, even with clade C (e.g., ZM197M), although this does not always work (e.g., CZA97). Because 2G12 is not trimer-specific, SEC is needed to purify trimers away from monomers, dimers, etc. For the same reason, 2G12 columns are NOT suitable for SOSIP.664 trimers that contain non-native trimer subpopulations; the latter species co-purify and cannot then be separated by SEC.
10 PGT145 columns for purifying SOSIP.664 trimers PGT145 is being made as a GMP reagent as a Scripps CHAVI-ID supplement (provisionally). Very broadly reactive across clades, although some failures (e.g., CZA97, clade C). Completely trimer-specific, so SEC is NOT needed at preclinical level (i.e., one-step purification of native trimers). Can be used to eliminate V3-clipped clade B trimers (e.g., B41), but there are alternative ways to solve this problem. Elution can cause some closed SOSIP.664 trimers (e.g., BG505) to partially open up, as viewed by EM, but emerging antigenicity and immunogenicity data indicate that this is NOT a major concern.
11 If you don t have a native structure to start with, using a bnab column won t help Because the 2G12 epitope is not trimer-specific, 2G12 columns are NOT suitable for uncleaved gp140s that do not contain native trimers. A PGT145 column also won t work
12 Other bnab columns We use PGT151 columns to make at least one native-like SOSIP.664 trimer (CZA97, clade C). Like PGT145, PGT151 is fully trimer-specific (i.e., one-step purification). Max Crispin has used PG9 and b12 columns to purify BG505 SOSIP.664 trimers with comparable glycan content and EM appearance to 2G12- or PGT145-purified trimers. GMP-quality bnabs being made for therapy trials include 1074, 3BNC117, PGT121, VRC01. In principle some of them could be useful for Env protein purification.
13 The glycan profiles of Env proteins Influences of purification strategies Native-like SOSIP.664 trimers are homogeneous and have a high oligomannose content very similar to native (virionderived) trimers (60-70%). For BG505 SOSIP.664 trimers this is independent of the bnab used for purification. Uncleaved gp140s with non-native structures have a much lower (30-40%), non-native oligomannose content (i.e., their glycans are more highly processed). Gp120 monomers are heterogeneous; their glycan content can be influenced by the purification method, but is generally lower (~35-45%) than for SOSIP.664 trimers. Pritchard/Crispin et al. Cell Reports (in press)
14 Epitopes for bnabs used to purify BG505 SOSIP.664 trimers for glycan analysis 2G12 gp120-subunit epitope PGT145 Trimer-specific apex epitope PGT151 Trimer-specific gp120-gp41 interface epitope Top views Side views
15 BG505 SOSIP.664 trimers purified via different bnabs all have very similar high oligomannose (native-like) glycan profiles 2G12 PGT145 PGT T-cell expressed trimers, purified by bnab columns followed by SEC
16 In contrast, the mannose content of BaL gp120 monomers is influenced by how they are purified Ni 2+ /NTA-reactive (intermediate mannose) 2G12 non-reactive (low mannose) 2G12 reactive (high mannose) His-tagged BaL gp120 expressed in 293T cells and purified via Ni 2+ -NTA or 2G12 columns
17 Subtype B native-like B41 SOSIP.664 trimers (Pugach et al J Virol 89, 3380) Antigenically comparable to BG505, highly immunogenic (unpublished results). V3 clipping seen when expressed in 293T cells (common to most subtype B Env proteins of all designs). Clipping due to serum proteases. Prevented by expressing trimers in 293F cells without serum. Alternatively, purify trimers via a PGT145 column (clipped trimers don t bind). Purified, non-clipped B41 SOSIP.664 trimers are fully native-like when viewed by EM. Native-like, high-mannose glycan profile, as per BG505 SOSIP.664 trimers (Max Crispin unpublished results).
18 V3 clipping and how to prevent it Subtype B V3 contains scissile sites (rare in other subtypes) Thrombin-family proteases most important Clements/Moore ARHR 1991 Critical contributions to solving the problem from Bob Whalen s group: clipping proteases are in serum (e.g., FCS) Du et al Prot Exp Pur 59, 223 Pugach et al. J Virol T + serum, 2G12/SEC BG505 SOSIP kda 70 kda B41 SOSIP.664 Serum is the problem B41 SOSIP.664 trimers 293T CHO 293F 10% 1% 0% serum B41 293T + serum, different columns gp120 trimer trimer 2G12 PGT145
19 Env protein design and purification strategies both matter CZA97 and 92UG037 Env proteins a case history Uncleaved gp140-fd-his proteins based on the CZA97 (clade C) and 92UG037 (clade A) sequences have been extensively studied in recent years (*) and are or have been relevant to GMP/clinical trial programs. They are claimed to be native trimers after purification via Ni 2+ /NTA columns followed by SEC. We have made these proteins together with SOSIP.664-His and other versions, to study the influence of Env design and purification strategies on native structure. Nkolola et al J Virol 84, Kovacs et al PNAS 109, Nkolola et al Vaccine 32, Kovacs et al PNAS 111,
20 If you want to make native trimers you have to start with the right design Well, soorr, if I were going to Dublin I wouldn t be starting from here Is the road to Dublin, my good man? XXXXXXXXXXXXXXXXXXXX
21 My Env proteins bind a lot of bnabs (But what does bind mean?) Many/most of the claims that uncleaved gp140s have native conformations and bind conformationally sensitive bnabs are based on a misuse of SPR methods. A signal in certain assays, particularly SPR, is a not sufficient measure of trimer antigenicity. Suppose 5% of the Env proteins in a population are properly folded and express, say, the PGT145 epitope If the binding assay SELECTS for that 5% and ignores the 95%, you get a highly misleading answer about the properties of the bulk population
22 Stoichiometry matters the importance of having a sense of proportion Take Add Sample Mmmm, I can taste something sweet! Great for my breakfast!!!!
23 How not to analyze non-homogenous Env proteins by SPR Flow over chip Mixture of native (epitope present) and non-native Env proteins (epitope absent) bnab on chip Signals from bnab-bound native Env BUT The majority population of nonnative Env fails to bind, is discarded and is invisible in the assay Drain This commonly used assay format can detect the PRESENCE of an epitope among the total population of Env proteins in a heterogeneous mixture but says nothing about the PROPORTION of Env proteins that express it. What binds to the SPR chip is not representative of the bulk properties of the unfractionated immunogen.
24 A better way to use SPR to analyze Env proteins (Yasmeen/Klasse Retrovirology 11, 41) MAbs flow over chip Signals from MAb binding to native Env bnab-purified native Env with His-tag Chip-immobilized anti-his MAb The method measures the proportion of antigenic trimers as well as kinetic constants and thereby affinities; it is best used for comparative studies (e.g., native vs. non-native Env; NAbs vs. non-nabs).
25 But only if the cosmetic treatment involves improvements to BOTH the Env design AND the purification method
26 Summary Env design and the purification method are both important Native-like soluble trimers can be made by several methods that all involve stabilizing the gp120-gp41 and gp41-gp41 associations. The fully cleaved BG505 SOSIP.664 trimer is the present paradigm but many others are now being made. Traditional uncleaved gp140s cannot be rescued via purification. Uncleaved gp140s can adopt native-like structures but ONLY if a flexible linker is inserted between gp120 and gp41 AND additional stabilizing changes are added (at minimum I559P, better + SOS). BG505 SOSIP.664 trimers and several others (e.g., B41) can be purified by 2G12 or even via His-tags because they are ~100% native-like. For other SOSIP.664 constructs and stabilized uncleaved gp140s, bnab positive selection (e.g., PGT145) or, as used by other groups, negative selection (F105), is needed to isolate the native trimer fraction.
27 Immunogenicity of SOSIP.664 trimers vs. uncleaved gp140s (Sanders et al., Science, in press) Autologous Tier-2 NAb responses to various Env proteins in Tzm-bl assay
28 Acknowledgements WCMC AMC Scripps Al Cupo Rogier Sanders Gabe Ozorowski PJ Klasse Chris Cottrell Tom Ketas Andrew Ward Pavel Pugach Ian Wilson Rajesh Ringe Anila Yasmeen And all members of the WCMC/AMC/Scripps HIVRAD team Funding support: NIAID HIVRAD grant (Program Office Jim Bradac) XXXXX Trimers
Novel HIV-1 envelope proteins to induce neutralizing antibodies
Novel HIV-1 envelope proteins to induce neutralizing antibodies Rogier Sanders Academic Medical Center, University of Amsterdam, Netherlands Weill Medical College of Cornell University, New York, U.S.A.
More informationEuropean AIDS Vaccine Initiative 2020
European AIDS Vaccine Initiative 2020 Proposal Acronym: EAVI2020 www.eavi2020.eu https://www.facebook.com/eavi2020 A 23 million euro initiative to accelerate the search for an effective HIV vaccine Unites
More informationProgress in Improving the HIV Envelope Manufacturing Process
Progress in Improving the HIV Envelope Manufacturing Process Third HIV Env Manufacturing Workshop Division of AIDS/NIAID/NIH and the Global HIV Vaccine Enterprise Phillip Berman Department of Biomolecular
More informationDesign and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo
1 2 3 4 5 6 7 8 9 1 11 12 13 14 15 16 17 18 19 2 21 22 23 24 25 26 27 28 29 3 31 32 33 34 Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing
More informationThe World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.
The World Leader in SPR Technology Jimmy Page, PhD, Biacore, Inc. Objectives of Biacore Experiments Yes/No Data» Is there binding?» Ligand Fishing Concentration Analysis: How MUCH? Active Concentration
More informationLecture 7: Affinity Chromatography-II
Lecture 7: Affinity Chromatography-II We have studied basics of affinity purification during last lecture. The current lecture is continuation of last lecture and we will cover following: 1. Few specific
More informationPredicting and Understanding HIV-1 Resistance to Broadly Neutralizing Antibodies. Anna Feldmann Max Planck Institute for Informatics
Predicting and Understanding HIV-1 Resistance to Broadly Neutralizing Antibodies Max Planck Institute for Informatics Motivation HIV-1 drug target space is limited Drug resistance emergence under HAART
More informationPassive Immunization Trials to Inform Vaccine Design
Passive Immunization Trials to Inform Vaccine Design Points for Consideration from deliberations held at the August 8, 2014 workshop Contents I. Introduction... 2 II. Types of trials... 2 1. Therapeutic
More informationBiophysical characterization of proteinprotein
Biophysical characterization of proteinprotein interactions Rob Meijers EMBL Hamburg EMBO Global Exchange Lecture Course Hyderabad 2012 Bottom up look at protein-protein interactions Role of hydrogen bonds
More informationLecture 8: Affinity Chromatography-III
Lecture 8: Affinity Chromatography-III Key words: Chromatography; Affinity chromatography; Protein Purification During this lecture, we shall be studying few more examples of affinity chromatography. The
More informationSupporting Information
Supporting Information Alam et al. 10.1073/pnas.0908713106 SI Materials and Methods Expression Constructs. We produced synthetic genes for the Fv fragments of mab 4E10 (Amoytop) and used pet-21a( ) (Novagen)
More informationTime-course, negative-stain electron microscopy based analysis for investigating protein protein interactions at the single-molecule level
ARTICLE cro Author s Choice Time-course, negative-stain electron microscopy based analysis for investigating protein protein interactions at the single-molecule level Received for publication, July 28,
More informationStrep-Spin Protein Miniprep Kit Catalog No. P2004, P2005
INSTRUCTION MANUAL Strep-Spin Protein Miniprep Kit Catalog No. P2004, P2005 Highlights Fast protocol to purify Strep-tagged proteins from cell-free extracts Screen your recombinant colonies directly for
More informationBIOC 463A Expt. 4: Column Chromatographic Methods Column Chromatography
Column Chromatography Chromatography is the process use to separate molecules based on SOME physical property of the molecule: Mass (i.e. size) Charge Affinity for ligands or substrates Hydrophobic interactions
More informationSupplementary Table 1: Antigenic regions/sites on Ebola-GP identified using GFPDL*
Supplementary Table 1: Antigenic regions/sites on Ebola-GP identified using GFPDL* Site AA Sequence 3x10 6 3x10 6 20x10 6 20x10 6 100x10 6 100x10 6 Post-1 st Post-2 nd Post-1 st Post-2 nd Post-1 st Post-2
More informationSUMOstar Gene Fusion Technology
Gene Fusion Technology NEW METHODS FOR ENHANCING FUNCTIONAL PROTEIN EXPRESSION AND PURIFICATION IN INSECT CELLS White Paper June 2007 LifeSensors Inc. 271 Great Valley Parkway Malvern, PA 19355 www.lifesensors.com
More informationWestern-GUARANTEED Antibody Service FAQ
Western-GUARANTEED Antibody Service FAQ Content Q 1: When do I need a Western GUARANTEED Peptide Antibody Package?...2 Q 2: Can GenScript provide a Western blot guaranteed antibody?...2 Q 3: Does GenScript
More informationRefolding the HCV E2 glycoprotein to enhance immunogenicity
Refolding the HCV E2 glycoprotein to enhance immunogenicity Lilian Phu, Rob Center, Pantelis Poumbourious, Heidi Drummer Viral Entry and Vaccines Laboratory 1 E2 glycoprotein E2 RBD Mediates viral entry
More informationStrep-Spin Protein Miniprep Kit Catalog No. P2004 & P2005
INSTRUCTION MANUAL Strep-Spin Protein Miniprep Kit Catalog No. P2004 & P2005 Highlights Fast & Simple: Purify Strep-tagged proteins from cell-free extracts using a spin-column in 7 minutes High-Quality:
More informationHis-Spin Protein Miniprep
INSTRUCTIONS His-Spin Protein Miniprep Catalog No. P2001 (10 purifications) and P2002 (50 purifications). Highlights Fast 5 minute protocol to purify His-tagged proteins from cell-free extracts Screen
More informationStreamline Your Antibody Enrichment Using Scalable Magnetic Bead-Based Chemistries
Streamline Your Antibody Enrichment Using Scalable Magnetic Bead-Based Chemistries Samantha Lewis, Ph.D. 2013. Webinar Outline Introduction Magnetic Bead-Based Method Overview Scalability Chemistries o
More informationRevised Immunogenicity Guideline: Assays and methods- Presentation of the draft guideline and introduction of the topics for discussion
Revised Immunogenicity Guideline: Assays and methods- Presentation of the draft guideline and introduction of the topics for discussion Robin Thorpe & Meenu Wadhwa Revised Guideline: Differences from original
More informationRecombinant Antibody Production in Therapeutic Antibody Projects. Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016
Recombinant Antibody Production in Therapeutic Antibody Projects Keshav Vasanthavada Senior Marketing Specialist, GenScript April 7, 2016 Presentation Outline 1 2 3 4 5 Introduction Recombinant Ab Production
More informationPurification of (recombinant) proteins. Pekka Lappalainen, Institute of Biotechnology, University of Helsinki
Purification of (recombinant) proteins Pekka Lappalainen, Institute of Biotechnology, University of Helsinki Physical properties of proteins that can be applied for purification -size -charge (isoelectric
More informationKinetics Review. Tonight at 7 PM Phys 204 We will do two problems on the board (additional ones than in the problem sets)
Quiz 1 Kinetics Review Tonight at 7 PM Phys 204 We will do two problems on the board (additional ones than in the problem sets) I will post the problems with solutions on Toolkit for those that can t make
More informationCat. No. MG17PG-1ml XPRESSAFFINITY PROTEIN G- MAGNETIC NANOPARTICLES (MNP) FOR RESEARCH APPLICATIONS
Cat. No. MG17PG-1ml XPRESSAFFINITY PROTEIN G- MAGNETIC NANOPARTICLES (MNP) FOR RESEARCH APPLICATIONS Product Description: MagGenome s Protein G-MNP provides a fast and convenient method for affinity based
More informationTarget/drug interference considerations in immunogenicity assessment
Target/drug interference considerations in immunogenicity assessment Eric Wakshull, PhD Senior Scientist March 9, 2016 EMA Workshop on Immunogenicity Outline Page 2 Basic Immunogenicity screening assay
More informationInterference from Fc-Fc Interactions in Bridging Immunogenicity Assays for IgG4 mab Therapeutics
Interference from Fc-Fc Interactions in Bridging Immunogenicity Assays for IgG4 mab Therapeutics November, 2014 Michael Partridge Ph.D. IgG4 Antibody Therapeutics Natalizumab (Tysabri): Marketed Pembrolizumab
More informationAims: -Purification of a specific protein. -Study of protein-protein interactions
Aims: -Purification of a specific protein -Study of protein-protein interactions This is a reliable method for purifying total IgG from crude protein mixtures such as serum. Protein A (linked to resin
More informationImmobilized Streptavidin Resin
438PR-01 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Immobilized Streptavidin Resin (Cat. # 786-390, 786-590, 786-591, 786-592) think
More informationDesign and Validation of a Non Cell-based Receptor Binding Assay for the Detection of Neutralizing Antibodies to a Biological Therapeutic
Design and Validation of a Non Cell-based Receptor Binding Assay for the Detection of Neutralizing Antibodies to a Biological Therapeutic Shalini Gupta Associate Director Amgen, Thousand Oaks, CA shalinig@amgen.com
More informationApplications of HTRF and Tag-lite Assays for HTP Antibody Screening
Applications of HTRF and Tag-lite Assays for HTP Antibody Screening Brigitte Devaux, PhD Bristol Myers Squibb, Redwood City CA HTRF Symposium April 25, 2013 1 Introduction Generate human therapeutic antibodies
More informationAntigens & Antibodies II. Polyclonal antibodies vs Monoclonal antibodies
A Brief Review of Antibody Structure A Brief Review of Antibody Structure The basic antibody is a dimer of dimer (2 heavy chain-light chain pairs) composed of repeats of a single structural unit known
More informationAffigenix Biosolutions Private Ltd, 265/ 1F, KSSIDC Industrial Area Bangalore, Karnataka,India
Host Cell Protein & Other Impurity Clearance Assays for Biosimilar Development Omics Biowaivers, Biologics & Biosimilars- Oct 29, 2014 Affigenix Biosolutions Private Ltd, 265/ 1F, KSSIDC Industrial Area
More informationImplementation of the Next Generation Effector Function Assays for Comparability Assessments
Implementation of the Next Generation Effector Function Assays for Comparability Assessments March 25, 2014 Poonam Aggarwal Bioassays 2014: Scientific Approaches & Regulatory Strategies to be held March
More informationAFFINITY HIS-TAG PURIFICATION
DESCRIPTION Resins are products that allow batch or column purifications. This product is supplied as a suspension in 20% ethanol. INSTRUCTIONS The resins are adapted to work mainly in native conditions
More informationEnhance Your Protein Interaction Research with A New Level of Bench-Top Productivity
LAMDAGEN C O R P O R A T I O N Enhance your research with real-time monitoring and quantitation of biomolecular binding with highly sensitive detection in a label-free format 9 Enhance Your Protein Interaction
More informationFDA Draft Guidance on Immunogenicity Testing
FDA Draft Guidance on Immunogenicity Testing Susan Kirshner, Ph.D. Associate Chief, Laboratory of Immunology Division of Therapeutic Proteins OBP/CDER/FDA EBF 2010 Guidance for Industry Assay Development
More informationExtracting Pure Proteins from Cells
Extracting Pure Proteins from Cells 0 Purification techniques focus mainly on size & charge 0 The first step is homogenization (grinding, Potter Elvejhem homogenizer, sonication, freezing and thawing,
More information8 th Vaccine & ISV Congress October 2014 Philadelphia, USA
8 th Vaccine & ISV Congress 26-28 October 2014 Philadelphia, USA 2014 Guinea Ebola Virus Recombinant Glycoprotein (GP) Nanoparticle Vaccine was Highly Immunogenic and Cross- Neutralized 1976 Ebola Virus
More informationT-cell response. Taken from NIAID: s.aspx
T-cell receptor T-cell response 1. Macrophage or dendritic cell digest antigen bacteria, virus 2. Fragments of Ag bind to major histo-compatiblity (MHC) proteins in macrophage. 3. MHC I-Ag fragment expressed
More informationUnique Challenges Associated with the Produc6on of Viral Glycoproteins
Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health Department of Health and Human Services Unique Challenges Associated with
More informationGenes to Proteins to Antibodies
Genes to Proteins to Antibodies About Us Fusion Antibodies is a CRO established in 2001 as a spin-out from Queen s University Belfast. The company building is situated in a charming area of Springbank
More informationCorporate Tutorial IBA T-CATCH. Cell isolation in pipette tips. ISCT, Paris Lothar Germeroth
Corporate Tutorial IBA T-CATCH Cell isolation in pipette tips ISCT, Paris 2014 Lothar Germeroth Workshop IBA Introduction of the Streptamer technology Staining with Streptamers off rate assay T-CATCH Cell
More informationSUMO Technology For Peptides
SUMO Technology For Peptides NOVEL METHODS FOR RAPID RECOMBINANT PEPTIDE EXPRESSION AND PURIFICATION Peptides for Therapeutic, Diagnostics, Vaccines and Industrial Applications cytokinespeptidelibrarieschemokines
More informationOPPF-UK Standard Protocols: Insect Cell Purification
OPPF-UK Standard Protocols: Insect Cell Purification Last Updated 6 th October 2016 Joanne Nettleship joanne@strubi.ox.ac.uk OPPF-UK SOP: Insect Cell Purification Table of Contents Suggested Schedule...
More informationBasic Biacore Course. Introduction to SPR technology. Biacore Training
Basic Biacore Course Introduction to SPR technology What Biacore measure Biomolecular Interactions Specificity Kinetics How Specific... How Fast & How Strong... Affinity Concentration Thermodynamics How
More informationHOOK 6X His Protein Purification (Yeast)
G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name HOOK 6X His Protein Purification (Yeast) For The Purification of His Tagged Proteins from
More informationHOOK 6X His Protein Purification (Bacteria)
182PR-02 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name HOOK 6X His Protein Purification (Bacteria) For The Purification Of His-Tagged Proteins
More informationImmunogenicity. How to deal with? Nathalie Macé Sanofi, Biomarkers & Biological analyses Unit
Immunogenicity How to deal with? Nathalie Macé Sanofi, Biomarkers & Biological analyses Unit Club Phase I, 22 March 2016 1 Outline Introduction to immunogenicity Analytical challenges for immunogenicity
More informationProteoGenix. Life Sciences Services and Products. From gene to biotherapeutics Target Validation to Lead optimisation
ProteoGenix Life Sciences Services and Products From gene to biotherapeutics Target Validation to Lead optimisation ProteoGenix Philippe FUNFROCK, founder and CEO French company located in Strasbourg,
More informationGLYCOENGINEERING FOR THERAPEUTIC PROTEINS. Technical Journal Club, 15 th July Sandra Ivic
GLYCOENGINEERING FOR THERAPEUTIC PROTEINS Technical Journal Club, 15 th July 2014 Sandra Ivic MAMMALIAN GYLCAN BIOSYNTHETIC PATHWAY Consensus sequence for N- Glycans: N-X-S/T No consensus sequence found
More informationFig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.
1 Integration of Structure-Based Drug Design and SPR Biosensor Technology in Discovery of New Lead Compounds Alexis S. Ivanov Institute of Biomedical Chemistry RAMS, 10, Pogodinskaya str., Moscow, 119121,
More informationFDA HCP assays are current the weakest analytical link in the total control strategy for biotech products
FDA HCP assays are current the weakest analytical link in the total control strategy for biotech products What are the best ways to prepare antigen/antibody reagents with highest HCP coverage? There was
More informationTECHNICAL BULLETIN. Ni-CAM HC Resin High Capacity Nickel Chelate Affinity Matrix. Product No. N 3158 Storage Temperature 2 8 C
Ni-CAM HC Resin High Capacity Nickel Chelate Affinity Matrix Product No. N 3158 Storage Temperature 2 8 C TECHNICAL BULLETIN Product Description Ni-CAM affinity resin (Ni-CAM) is an immobilized metal-ion
More informationWhat are the best ways to prepare antigen/antibody reagents with highest HCP coverage?
What are the best ways to prepare antigen/antibody reagents with highest HCP coverage? Regulators remained agnostic on technical approaches so long as the all of the HCP ELISA reagents are demonstrated
More informationPROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%)
1 AFFINITY HIS-TAG PURIFICATION PROCEDURE FOR USE NICKEL NTA Magnetic Agarose Beads (5%) DESCRIPTION Nickel NTA Magnetic Agarose Beads are products that allow rapid and easy small-scale purification of
More informationElectron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG505 Envelope Trimer Immunization
Article Electron-Microscopy-Based Epitope Mapping Defines Specificities of Polyclonal Antibodies Elicited during HIV-1 BG55 Envelope Trimer Immunization Graphical Abstract Authors Matteo Bianchi, Hannah
More informationMolecular Interactions Research
Molecular Interactions Research Group (MIRG) Satya P. Yadav, Aaron P. Yamniuk, John Newitt, Michael L. Doyle, Ed Eisenstein, Thomas A. Neubert Presented at: ABRF 2013 (RG9 session), Palm Springs, CA March
More informationProduct. Ni-NTA His Bind Resin. Ni-NTA His Bind Superflow. His Bind Resin. His Bind Magnetic Agarose Beads. His Bind Column. His Bind Quick Resin
Novagen offers a large variety of affinity supports and kits for the purification of recombinant proteins containing popular peptide fusion tags, including His Tag, GST Tag, S Tag and T7 Tag sequences.
More informationPerform reproducible immunoprecipitation in less than 40 minutes
Perform reproducible immunoprecipitation in less than 40 minutes Dynabeads products Immunoprecipitation made easy with low nonspecific binding, high yield, and reproducibility Magnetic beads have become
More informationTable 1 Types of Immuno-experiments and associated labels
GUIDE TO ANTIBODY LABELING AND DETECTION Anyone new to this field will find in the literature a bewildering number of antibody labeling protocols. It is difficult for the newcomer to know what the critical
More informationSUPPLEMENTARY INFORMATION
Results Construct purification and coupling. Two A1-GP1bα ReaLiSM constructs, with and without cysteine residues near the N and C-termini (Fig. S2a), were expressed and purified by Ni affinity chromatography
More informationOpportunities for Accelerating Cell Line Development and Beyond
Opportunities for Accelerating Cell Line Development and Beyond European CM&C Strategy Forum May 24, 2017 Christopher Frye, Ph.D. Research Advisor & Group Leader Bioprocess R&D Presentation Outline CM&C
More informationAdvanced Therapeutic Antibody Discovery with Multiplexed Screening
Advanced Therapeutic Antibody Discovery with Multiplexed Screening White Paper Scientists need powerful tools that can deliver results to fully understand the ability of candidate antibodies to interrupt
More informationIMMUNOPRECIPITATION TROUBLESHOOTING TIPS
IMMUNOPRECIPITATION TROUBLESHOOTING TIPS Creative Diagnostics Abstract Immunoprecipitation (IP) is the technique of precipitating a protein antigen out of solution using an antibody that specifically binds
More informationIn Vitro Glycoengineering - Its Application and Effect on IgG1
In Vitro Glycoengineering - Its Application and Effect on IgG1 Glycobiology Conference, 2015 AAPS National Biotechnology Conference, June 8-10, 2015, San Francisco Dietmar Reusch, Marco Thomann, Development
More informationMonoclonal Antibodies for Treatment and Prevention of HIV-1 CROI Charles Boucher Erasmus MC
Monoclonal Antibodies for Treatment and Prevention of HIV-1 CROI 2018 Charles Boucher Erasmus MC Introduction: Human monoclonal antibodies Monoclonal Antibodies: Are identical immunoglobulins made by clone
More informationStrategies to Improve Drug Tolerance in Nab Assays
Strategies to Improve Drug Tolerance in Nab Assays Steven J Swanson, PhD Senior Vice President, Research ImmunoCellular Therapeutics Ltd steven.swanson@imuc.com AAPS National Biotech Conference June 2015
More informationProtein Purification and Characterization Techniques. Nafith Abu Tarboush, DDS, MSc, PhD
Protein Purification and Characterization Techniques Nafith Abu Tarboush, DDS, MSc, PhD natarboush@ju.edu.jo www.facebook.com/natarboush Extracting Pure Proteins from Cells Purification techniques focus
More informationBACTERIAL PRODUCTION EXPRESSION METHOD OVERVIEW: PEF # GENE NAME EXPRESSION VECTOR MOLECULAR WEIGHT kda (full-length) 34.
BACTERIAL PRODUCTION PEF # GENE NAME EXPRESSION VECTOR MOLECULAR WEIGHT 2015-XXXX XXXX pet-32a 50.9 kda (full-length) 34.0 kda (cleaved) EXPRESSION METHOD OVERVIEW: Plasmid DNA was transformed into BL21
More informationThe Simple Western Approach to Vaccine and Clinical Protein Research
The Simple Western Approach to Vaccine and Clinical Protein Research The Simple Western Approach to Vaccine and Clinical Protein Research Broadcast Date: Thursday, October 4, 2012 Time: 1 pm ET, 10 am
More informationStrep-Tactin XT Spin Column
Strep-Tactin XT Spin Column Purification Protocol Last date of revision Last June date 2017 of revision June 2017 Version PR90-0001 Version PR90-0001 For research use only Important licensing information
More informationMBios 478: Mass Spectrometry Applications [Dr. Wyrick] Slide #1. Lecture 25: Mass Spectrometry Applications
MBios 478: Mass Spectrometry Applications [Dr. Wyrick] Slide #1 Lecture 25: Mass Spectrometry Applications Measuring Protein Abundance o ICAT o DIGE Identifying Post-Translational Modifications Protein-protein
More informationThe United States Pharmacopeia Strategy on Biotherapeutic Products Standards. Jaap Venema, Ph.D. Chief Science Officer & Chair, Council of Experts
The United States Pharmacopeia Strategy on Biotherapeutic Products Standards Jaap Venema, Ph.D. Chief Science Officer & Chair, Council of Experts U.S. Pharmacopeia Who We Are Scientific, independent, volunteer-driven,
More informationBuilding a deep immuno-oncology portfolio in less than a year. David Johnson, PhD PEGS Spring 2018
Building a deep immuno-oncology portfolio in less than a year David Johnson, PhD PEGS Spring 2018 Improving early development 15-20 years, >$billion for an innovative new drug Attrition rate Target discovery
More informationGE Biacore T Check that the waste bottle is empty.
GE Biacore T200 General Care and Maintenance The instrument should be left ON at all times, and in Standby Mode. Report problems immediately in the booking system: https://ppms.us/hms-cmi. Refer to the
More informationAffimer Biotherapeutics: The preclinical development and validation of a PD-L1 antagonist in mouse
Affimer Biotherapeutics: The preclinical development and validation of a PD-L1 antagonist in mouse NGPT San Diego, 6 th June 2017 Amrik Basran Chief Scientific Officer Avacta Life Sciences Avacta Life
More informationDesign of self-assembling protein nanomaterials as next-generation vaccine scaffolds. Neil King March 15, 2016
Design of self-assembling protein nanomaterials as next-generation vaccine scaffolds Neil King March 15, 2016 Protein self-assembly enables specialized functions; our goal is to design new self-assembling
More informationIntroduction to Protein Purification
Introduction to Protein Purification 1 Day 1) Introduction to Protein Purification. Input for Purification Protocol Development - Guidelines for Protein Purification Day 2) Sample Preparation before Chromatography
More informationChapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology
Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing
More information1. Immunization. What is Immunization? 12/9/2016. Chapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology
Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing
More informationAccelerate mab Characterization Using Automated Sample Prep
Accelerate mab Characterization Using Automated Sample Prep David Knorr, Ph.D. Automation Solutions Ning Tang, Ph.D. LC/MS 15 February 2012 Page 1 Protein Sample Processing Workflows Glycan Profiling Biological
More informationModular DSP approaches for complex non-mab molecules
Modular DSP approaches for complex non-mab molecules Dr. Stefan R. Schmidt MBA SVP Process Science & Production Agenda 1 Introduction 2 3 4 5 Process related impurities Product related impurities Virus
More informationHIV ENV MANUFACTURING WORKSHOP A workshop sponsored by the Division of AIDS/NIAID/NIH and the Global HIV Vaccine Enterprise
HIV ENV MANUFACTURING WORKSHOP A workshop sponsored by the Division of AIDS/NIAID/NIH and the Global HIV Vaccine Enterprise Strategies for Facilitating Regulatory Pathways Tanya Scharton-Kersten, PhD Senior
More informationPurification Polishing of His-tagged proteins
Purification Polishing of His-tagged proteins Application of Centrifugal Vivapure Ion-exchange Membrane Devices to the Purification Polishing of Histagged Proteins for Crystallization. Dr. Mark, McAlister
More informationImmunoglobulins. Structure
Immunoglobulins Structure Definitions Immunoglobulin is a generic term that refers to a diverse group of molecules found in the blood and tissue fluids They are soluble globulin molecules and they generally
More informationChallenges to measuring intracellular Ca 2+ Calmodulin: nature s Ca 2+ sensor
Calcium Signals in Biological Systems Lecture 3 (2/9/0) Measuring intracellular Ca 2+ signals II: Genetically encoded Ca 2+ sensors Henry M. Colecraft, Ph.D. Challenges to measuring intracellular Ca 2+
More informationPhage Antibody Selection With Reichert SPR System
Phage Antibody Selection With Reichert SPR System Reichert Technologies Webinar April 4, 2016 Mark A. Sullivan, Ph.D. Department of Microbiology and Immunology University of Rochester Presentation Outline
More informationAgilent AssayMAP Bravo Platform AUTOMATED PROTEIN AND PEPTIDE SAMPLE PREPARATION FOR MASS SPEC ANALYSIS
Agilent AssayMAP Bravo Platform AUTOMATED PROTEIN AND PEPTIDE SAMPLE PREPARATION FOR MASS SPEC ANALYSIS GET FAST, ACCURATE, REPRODUCIBLE RESULTS The Agilent AssayMAP platform is an easy to use yet flexible
More informationHOOK 6X His Protein Spin Purification (Bacteria)
222PR 03 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name HOOK 6X His Protein Spin Purification (Bacteria) For the Purification of His Tagged
More informationDiscovery on Target. Short Course Preview Deck
Discovery on Target Short Course Preview Deck Targeting of GPCRs with Monoclonal Antibodies Barbara Swanson, Ph.D. Sorrento Therapeutics, Inc. October 2014 GPCR Short Course Overview Introductions Brief
More informationSupplementary Figure 1.
Supplementary Figure 1. Assessment of quaternary structure of soluble RSV F proteins. Soluble variants of F proteins from A2 and B1 RSV strains were expressed in HEK293 cells. The cell culture supernatants
More informationCross Linking Immunoprecipitation
301PR 03 G-Biosciences 1-800-628-7730 1-314-991-6034 technical@gbiosciences.com A Geno Technology, Inc. (USA) brand name Cross Linking Immunoprecipitation Utilizes Protein A/G Agarose& DSS for Antibody
More informationNPTEL VIDEO COURSE PROTEOMICS PROF. SANJEEVA SRIVASTAVA
LECTURE-06 PROTEIN PURIFICATION AND PEPTIDE ISOLATION USING CHROMATOGRAPHY TRANSCRIPT Welcome to the proteomics course. Today, we will talk about protein purification and peptide isolation using chromatography
More informationWhat is an Aptamer? smallest unit of repeating structure
What is an Aptamer? apto: mer: to fit smallest unit of repeating structure Aptamers are single stranded folded oligonucleotides that bind to molecular (protein) targets with high affinity and specificity
More informationReviewers' comments: Reviewer #1 (Remarks to the Author):
Reviewers' comments: Reviewer #1 (Remarks to the Author): Modulating immune checkpoint pathways like CTLA-4 and PD-1 for cancer immunotherapy has gained much attention in recent years due to their immense
More informationPurification: Step 1. Lecture 11 Protein and Peptide Chemistry. Cells: Break them open! Crude Extract
Purification: Step 1 Lecture 11 Protein and Peptide Chemistry Cells: Break them open! Crude Extract Total contents of cell Margaret A. Daugherty Fall 2003 Big Problem: Crude extract is not the natural
More informationPurification: Step 1. Protein and Peptide Chemistry. Lecture 11. Big Problem: Crude extract is not the natural environment. Cells: Break them open!
Lecture 11 Protein and Peptide Chemistry Margaret A. Daugherty Fall 2003 Purification: Step 1 Cells: Break them open! Crude Extract Total contents of cell Big Problem: Crude extract is not the natural
More informationElicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
Resource Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches Graphical Abstract Authors Matthias Pauthner, Colin
More information